The efficacy and safety of flumazenil in reversing midazolam-induced paradoxical reaction in a child suffering from paroxysmal supraventricular tachycardia (PSVT) and undergoing radiofrequency ablation procedure has not been described before. We report a boy who had suffered for years from poorly controlled PSVT because of noncompliance to medications and was being sedated by midazolam and morphine (4 mg each) and prepared for radiofrequency ablation when he began attempting to speak, writhing and flailing his arms, for which physical restraint was required. We also review the current knowledge on the subject.
Introduction
Midazolam is the most frequently used sedative agent that is considered safe for patients of all ages. Rather than sedating and calming the patient, however, midazolam may sometimes precipitate hostility and even physical violence which may reach the point of necessitating restraining the patient until these 'paradoxical' responses wane spontaneously with supportive care (1) or are suppressed pharmacologically (2) (3) (4) (5) . Paradoxical reactions to benzodiazepines (BZD), which range from severe behavioural disturbances (e.g. agitation, paranoid reaction and psychosis) to physical hostility, aggression and rage, frequently require the interruption of the surgical procedure because of the threat of injury to both the patient and the staff.
Flumazenil, a specific antagonist of BZD, binds competitively to the central BZD receptor and reverses all of BZD's agonistic actions. It was shown to effectively abrogate the violent episodes of paradoxical reactions in animals (6) , in the elderly and in paediatric patients (3, 7) in general medical and surgical settings. The current report describes our experience of applying it for this purpose in a paediatric cardiac patient.
Case report
A 13-year-old Arab Israeli boy was referred to the cardiology laboratory because of paroxysmal supraventricular tachycardia (PSVT) of more than 4 years' duration. Some of the SVT episodes (180-220 bAEmin )1 ) were self-terminated while the rest were relatively well-controlled with daily amiodarone l00 mg and propranolol 15 mg, but relapses still occurred because of poor treatment compliance. Electrocardiographic (ECG) tracings during SVT suggested a concealed accessory pathway, most probably left-sided. Resting tracings showed only nonspecific T changes. The echocardiogram was normal.
Because of the patient's young age and his inability to understand Hebrew or English, taken together with the uncomfortable nature of the procedure and the need for him to remain immobile throughout the procedure, it was decided to carry out the electrophysiological study (EPS) and the eventual subsequent radiofrequency ablation (RFA 1 ) under monitored sedation . Systolic and  diastolic blood pressures, respiratory rate, 5-lead  ECG, pulse oximetry and endexpiratory carbon  dioxide were monitored noninvasively (AS/3 TM , Datex Ò , Helsinki, Finland), and the patient breathed 40% oxygen via a facemask. An infusion of midazolam and morphine was started until he became sleepy. After 4 mg midazolam and 4 mg morphine were infused, the rate was slowed to maintain him in a sleeping but arousable state (3, 8) .
At this point, 5 ml lidocaine 1.5% was injected in the right femoral area and 2 ml to the left antecubital fossa in order to insert venous catheters. Several minutes later, and before catheter insertion was accomplished, the boy began writhing, flailing his arms and attempting to speak. While sedated his utterances were recognized as being nonsensical, and he needed to be physically restrained on the operating table.
In order to exclude a light level of sedation as the cause of this reaction, additional midazolam and morphine (1 mg each) were administered but affected no change. Two i.v. injections of 0.05 mg flumazenil within a 10-s interval were administered to both diagnose and stop the reaction, which ceased within 20 s from administration of the second dose. When the patient awoke, his eyes were open, and he was calm, coherent and able to answer simple questions in Arabic. He said he was comfortable and pain free. The aberrant behaviour did not resume when he was allowed to fall asleep again. All haemodynamic and respiratory parameters remained stable throughout this event, except for a temporary increase in heart rate (from 68 to 83 bAEmin )1 ).
Afterwards, morphine 2 mgAEh )1 alone was infused to maintain a sleeping state and the procedure of electrophysiological study and radiofrequency ablation continued with a reproducible induction of sustained orthodromic atrioventricular (AV) reentrant tachycardia (160 bAEmin )1 ), involving a concealed accessory pathway with a relatively long conduction time (100 ms), which was ablated by a radiofrequency pulse of 50 watts. A retrograde pathway of a rapid (250 bAEmin )1 ) atypical AV nodal reentry tachycardia (fast/slow) induced by i.v. isoproterenol and atropine was also ablated by a single radiofrequency pulse of 55 watts. During the entire 40-min procedure, the patient slept calmly and all the monitored vital signs were normal.
At the end of the procedure, the boy awoke spontaneously. He was calm and pain free and had no recollection of the aggressive episode. He was transferred to the intermediate cardiac care unit for observation and discharged home the following day without further incident.
Discussion
Electrophysiological studies are a new and promising technique aimed at terminating rapid ventricular or supraventricular heart rhythm that cannot be controlled by medications. Aberrant pathway ablation is applicable at all ages and, as in adults, it requires that the child lies completely still. Previous data showed that several anaesthetic agents could interfere with EPS and that positive pressure ventilation could interfere with ablation. Our protocol of midazolam and morphine infusion best enabled reliable, adjustable and steady-state sedation without interfering with myocardial responsiveness to the drugs used to unveil concealed pathways or to pulse ablation and without depressing ventilation or oxygenation.
Paradoxical reactions to BZD were first reported in 1961 by Boyle and Tobin whose patient manifested aggressive behaviour after being treated with oral chlordiazepoxide (9). Feldman (10) described a similar occurrence of diazepam being followed by rage attacks, Litchfield (11) reported two cases of aggressive behaviour following i.v. administration of diazepam, and another description of aggressive behaviour following i.v. midazolam was reported by Ricou et al. (12) .
The epidemiological significance of paradoxical events was not recognized until recently because of their unpredictability, the absence of data on predisposing characteristics and, probably, a low level of awareness. In one study on elderly patients, the incidence of such episodes among patients treated only by midazolam was assessed as being 10.2% (3) compared with 3.2% reported by Ricou et al. (12) and the 1% figure given in the Physicians Desk Reference (13). The estimated incidence of agitation and hostility in children under BZD sedation ranged between 1.4 (7) and 2% (14) (15) (16) in the preflumazenil era. Among three teenagers who were operated upon under regional anaesthesia and who reacted paradoxically to midazolam sedation (17) , the reaction in two of them was swiftly abrogated with flumazenil 0.1 mg i.v. During conscious sedation that was given during 222 endoscopic procedures in children (2.5-18 years) (18) , agitation, head shaking, restlessness and tachycardia occurred in 25 (11.3%): in two of these, the procedures were completed only after the i.v. administration of flumazenil (0.1 mg). An 11-year-old nephrotic boy who became confused and agitated 40 min after the oral administration of 17.5 mg midazolam was awakened satisfactorily by 0.15 mg flumazenil i.v. (19) . Retrograde amnesia remained intact in all these reported children, and the procedures were successfully and safely brought to completion in all, as it was in our patient. Another two reports described postmidazolam severe aggressive behaviour in four children during surgical procedures under conscious sedation who responded promptly to 0.2-0.3 mg flumazenil (20, 21) . These findings are of special importance now that midazolam has become the most used i.v. BZD for obtaining different levels of amnesia, sedation and anxiolysis in operating theatres and in outpatient facilities (2, 17, 21, 22) , as well as in the emergency department (8) . The latter publications on the use of flumazenil in reversing BZD-induced paradoxical reactions involved a total of 40 children, but none within a cardiac laboratory in preparation for electrophysiological studies. Additionally, the reversing effect of flumazenil had never been proven to be electrophysiologically innocuous for patients suffering from PSVT. As in the present case, flumazenil in a very low dose, i.e. 0.05-0.1 mg, reversed these episodes without leaving traces in the patient's recollection (3, 21) , and the sedative and amnesic effects persisted in an acceptable manner.
Abnormal and uncontrollable movements similar to paradoxical episodes can occur under a variety of conditions, among them BZD-induced decrease in ventilatory response to CO 2 , low respiratory rate or minute ventilation and hypoxia and, rarely, following drops of blood pressure in patients suffering from cerebrovascular accident, hypertension or in haemodynamically unstable individuals. The boy described in this report had normal respiratory and ventilatory parameters (including arterial oxygenation) and his blood pressure was stable, with the pulse rate changing only in parallel with the paradoxical reaction. Finally, we believe that our patient continued to sleep quietly after flumazenil administration, without reiterating the previous struggle, because of the concomitant morphine administration rather than as a result of resedation.
The doses of midazolam that had been given before the onset of the reported occurrences varied extensively, from a maximum of 12 mg in a 70-min period (20) to as little as 4-7 mg per 70 kg weight, the latter being a dose that might undersedate some patients and lead to the induction of restlessness and agitation by yet unspecified stimuli. Additionally, a child's moving or fighting might be attributable to an uncomfortable situation to which he was not willing or not yet able to consent. To exclude these possibilities, although our patient was at the desired sedation level, the physician ordered the further administration of midazolam and morphine before using flumazenil.
Overdose of local anaesthetic agents can induce abnormal movements. This likelihood was ruled out in our reported case because, had it occurred at all, it should have taken place immediately after lidocaine administration and would not have ceased when the patient had awakened or by the administration of flumazenil. Also, the total dose of the administered lidocaine was below its known toxic level on the central nervous system. Finally, if pain is not alleviated in a sedated patient, it may also result in an abnormal reaction that can develop into aggressive behaviour perioperatively (11) . Our patient did not complain of having experienced pain at any time.
The influence of general anaesthesia on EPS and RFA, including the cardiovascular effects of of flumazenil, merits special consideration. Schaffer and colleagues concluded that SVT was inducible with both desflurane and fentanyl during electrophysiological studies in children; however, the former also reduced the mean arterial pressure and shortened the sinus cycle length (23) . Propofol and isoflurane-based anaesthesia administered in children undergoing RFA because of SVT were found to slow the atrioventricular nodal conduction rate (propofol) and to prolong the ventricular repolarization (isoflurane) (24) . Another study even recommended not using propofol in children with ectopic atrial tachycardia because it suppressed dysrhythmogenicity during EPS that could not be induced by isoproterenol (25) . On the contrary, Lavoie et al. did not detect changes in senoatrial or atrioventricular node function in children undergoing RFA under propofol or isoflurane (26) . These reports were the reason for our using midazolam and morphine in all our patients.
Cardiac dysrhythmias have been reported in a very small number of drug-overdosed patients after the administration of flumazenil. Aarseth et al. (27) described four patients who developed SVT and one patient with ventricular ectopic beats (VPBs) in a nine-patient flumazenil group, vs two patients with SVT in a similar placebo group. Prischl et al. (28) also reported one patient with VPBs among 26 patients mostly intoxicated with BZD and other intoxicants who had been treated with flumazenil doses of up to 8 mg, and Short and colleagues (29) described VPB coupled with a brief run of ventricular tachycardia following the administration of flumazenil in a patient intoxicated with chloral hydrate and oxazepam. Marchant et al. (30) indicated that one of three drug intoxication cases resulted in very deep coma, haemodynamic and respiratory depression. Following the injection of flumazenil, that patient also developed repeated ventricular tachycardias, which were treated successfully with cardioversion. Noteworthy, there is an association between seizures and cardiac dysrhythmia: grand mal induces an increase in the blood level of catecholamines that, in the presence of myocardial-sensitizing drugs (e.g. 3 tricyclic antidepressant drugs [TCAD]) or blood metabolic disorder (e.g. acidosis) can precipitate dysrhythmia (30) . For this reason, respiratory, cardiac and metabolic conditions should be corrected before flumazenil is administered. The reason for the flumazenil-associated dysrhythmias in patients overdosed or treated with high doses of BZD and TCAD or structurally similar agents (e.g. carbamazepine) is that it reverses the protection afforded by the BZD against the cardiac dysrhythmogenic and proconvulsive properties of these drugs. Finally, among another three individuals who experienced uneventful cardiac dysrhythmia after being treated with flumazenil, two were later defined as being chloral hydrate overdose (a tachydysrhythmogenic substance with a high bioavailability) (31) (32) (33) . The dysrhythmias did not lead to clinical problems in any of these 10 patients.
It must be pointed out that most of the abovementioned cases of dysrhythmia occurred after high and rapidly injected i.v. doses of flumazenil (2.5-5 and even 8 mg) and not the currently acceptable prescriptions of 0.1-0.5 mg in adults (22) and 10-50 lgAEkg )1 in children (34) . Most of those earlyreported cases were also intoxications that were later proved to have been caused by mixed BZD and cardiotoxic drugs or these drugs with no concomitant BZD (e.g. TCAD and chloral hydrate). Indeed, flumazenil (0.1-0.4 mg intravenously) was used uneventfully to reverse the heavy sedation induced by combinations of diazepam, midazolam and methohexital administered for right and left cardiac catheterization in intracardiac refractory fulguration or cardioversion and for patients with severe coronary artery or valve disease (35, 36) . Even when similar high-risk cardiac patients were rapidly administered with i.v. flumazenil at doses ranging between 1-3 mg without previous BZD treatment, no abnormal changes in cardiovascular parameters were detected (37, 38) . Our own group reported that a high proportion of patients (71%) had no seizures or cardiac disturbances after flumazenil administration among a group of patients with high plasma TCAD concentrations (8) . We and others (39) suggested that cardiac adverse effects could be avoided by using a slow, incremental flumazenil dosage which selectively reverses BZD-induced agonistic and depressive effects. These latter reports associated with controlled clinical studies have subsequently led to the conclusion that withholding flumazenil therapy because of potential but rare adverse effects is not justified (40) , unless there is a history or physical findings suggestive of seizures, of an overdose of drugs that decrease seizure threshold or are tachydysrhythmogenic (e.g. TCAD, carbamazepine and chloral hydrate), or if there is an ECG that is suggestive of TCAD toxicity.
In conclusion, the present report describes a beneficial effect of 0.05-0.1 mg flumazenil in a child who developed a midazolam-associated paradoxical reaction and the completion of the event within <30 s when the patient awoke in a tranquil state. This protocol appears neither to have deleterious myocardial rate effects nor to interfere with electrophysiological studies and radiofrequency ablation.
